Skip to main content

SYNOPSYS INC (SNPS) Stock Forecast 2025 - AI Price Prediction & Analysis


SYNOPSYS INC (SNPS) AI Stock Price Forecast & Investment Analysis

SYNOPSYS INC Stock Price Chart and Technical Analysis

Loading SYNOPSYS INC interactive price chart and technical analysis...

SYNOPSYS INC (SNPS) - Comprehensive Stock Analysis & Investment Research

Deep dive into SYNOPSYS INC's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about SYNOPSYS INC, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For SYNOPSYS INC: SYNOPSYS INC operates in the Technology sector, positioning it as a large-cap market leader.

SYNOPSYS INC (Stock Symbol: SNPS) is a leading company in the Technology sector , specifically operating within the Services-Prepackaged Software industry.

The organization employs approximately 13000 professionals worldwide .

The company has established itself as a major market leader with significant institutional backing.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing SYNOPSYS INC's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For SYNOPSYS INC: With $6435M in annual revenue and 188.5% net margin, the company demonstrates exceptional profitability.

Annual Revenue: $6435 million generating a 188.5% net profit margin .

Market Capitalization: $82300 million - Classified as a large-cap stock with institutional-grade stability.

Return on Equity (ROE): 18.9% - Excellent shareholder return efficiency, indicating strong management effectiveness.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for SYNOPSYS INC stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For SYNOPSYS INC: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for SYNOPSYS INC stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: SYNOPSYS INC's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For SYNOPSYS INC: Strong free cash flow generation demonstrates exceptional operational efficiency.

SYNOPSYS INC strategically competes in the highly dynamic Services-Prepackaged Software marketplace, positioning itself as a dominant large-cap market leader with significant competitive moats and institutional investor confidence .

The company demonstrates robust operational efficiency through strong free cash flow generation of $1579 million annually, complemented by impressive 23.8% year-over-year cash flow growth.

The company maintains a healthy 625.9% gross margin, indicating strong pricing power and operational efficiency.

SYNOPSYS INC (SNPS) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for SYNOPSYS INC stock analysis.

Loading SYNOPSYS INC comprehensive fundamental analysis and insider trading data...

Deep dive into SYNOPSYS INC's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if SYNOPSYS INC stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For SYNOPSYS INC: With a P/E ratio of 41.20, the market highly values future growth prospects.

P/E Ratio 41.20x
P/B Ratio 2.98x
Market Cap $82300M
EPS $12.90
Book Value/Share $148.91
Revenue/Share $34.70
FCF/Share $5.22
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently SYNOPSYS INC converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For SYNOPSYS INC: An ROE of 18.9% demonstrates excellent shareholder value creation.

ROE 18.9%
ROA 11.5%
ROIC 16.8%
Gross Margin 625.9%
Operating Margin 186.5%
Net Margin 188.5%
EBT Margin 22.7%
Tax Rate 6.7%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess SYNOPSYS INC's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For SYNOPSYS INC: A current ratio of 1.25 shows adequate liquidity.

Current Ratio 1.25x
Quick Ratio 0.99x
D/E Ratio 0.11x
Financial Leverage 1.66x
Interest Coverage 397.9x
Working Capital $409M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal SYNOPSYS INC's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For SYNOPSYS INC: Free cash flow of $1579M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $1698M
Free Cash Flow $1579M
Capital Spending $-119M
OCF Growth YoY 23.8%
FCF Growth YoY 39.2%
FCF/Sales 33.2%
CapEx/Sales 2.5%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively SYNOPSYS INC uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For SYNOPSYS INC: An asset turnover of 0.54x suggests room for improvement in asset utilization.

Asset Turnover 0.54x
Receivables Turnover 7.1x
Inventory Turnover 4.3x
Fixed Assets Turnover 4.6x
Days Sales Outstanding 51 days
Days Inventory 85 days
Payables Period 23 days
Cash Conversion Cycle 114 days
Understanding Financial Statement Data

What these metrics mean: Key figures from SYNOPSYS INC's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For SYNOPSYS INC: With annual revenue of $6435M, SYNOPSYS INC operates at significant scale.

Income Statement ($ Millions)
Total Revenue $6435M
R&D Expense $2043M
SG&A Expense $22M
Cost of Goods Sold $340M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 33%
Cash & Short-term Investments 19%
Total Liabilities 39%
Short-term Debt 1%
Accounts Receivable 8%
Inventory 2%
Dividend & Shareholder Information
Shares Outstanding 185M
Growth Metrics (YoY)
EPS Growth 1.9%

Latest SYNOPSYS INC Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting SYNOPSYS INC (SNPS) stock price and investment outlook.

SYNOPSYS INC Competitors & Peer Analysis - Technology Sector

Comparative analysis of SYNOPSYS INC against industry peers and competitors in the Technology sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ACIW Unlock Forecast - 30 Days FREE Trial $5324M 21.2x 3.8x
ADBE Unlock Forecast - 30 Days FREE Trial $141095M 20.3x 12.0x
AEYE Unlock Forecast - 30 Days FREE Trial $171M -61.5x 23.2x
AI Unlock Forecast - 30 Days FREE Trial $2571M -16.8x 3.2x
ALKT Unlock Forecast - 30 Days FREE Trial $2406M -75.9x 7.0x
ALRM Unlock Forecast - 30 Days FREE Trial $2522M 19.6x 3.2x
ALSAF Unlock Forecast - 30 Days FREE Trial $39M x x
ALSUF Unlock Forecast - 30 Days FREE Trial $6M x x
APCX Unlock Forecast - 30 Days FREE Trial $6M -0.8x 2.3x
API Unlock Forecast - 30 Days FREE Trial $1453M x 2.2x
APPN Unlock Forecast - 30 Days FREE Trial $2039M -27.3x -56.8x
ASAN Unlock Forecast - 30 Days FREE Trial $3325M -12.4x 14.8x
ATHR Unlock Forecast - 30 Days FREE Trial $70M x 11.8x
AVDX Unlock Forecast - 30 Days FREE Trial $2077M 1104.8x 3.0x
BAND Unlock Forecast - 30 Days FREE Trial $447M -30.3x 1.2x
BASE Unlock Forecast - 30 Days FREE Trial $1354M -10.2x 10.9x
BB Unlock Forecast - 30 Days FREE Trial $2678M -11.9x 3.7x
BBAI Unlock Forecast - 30 Days FREE Trial $3123M -3.9x 11.7x
BL Unlock Forecast - 30 Days FREE Trial $3075M 34.9x 7.4x
BLIN Unlock Forecast - 30 Days FREE Trial $15M -2.4x 1.5x
BLKB Unlock Forecast - 30 Days FREE Trial $3140M 88.2x 35.7x
BMR Unlock Forecast - 30 Days FREE Trial $43M x 2.4x
BNZI Unlock Forecast - 30 Days FREE Trial $8M x 2.6x
BRZE Unlock Forecast - 30 Days FREE Trial $2804M -36.2x 4.7x
BSQKZ Unlock Forecast - 30 Days FREE Trial $48641M 16.4x 2.2x
BSY Unlock Forecast - 30 Days FREE Trial $16767M 65.9x 14.4x
CANG Unlock Forecast - 30 Days FREE Trial $1004M x 0.3x
CBDW Unlock Forecast - 30 Days FREE Trial $0M x x
CCLD Unlock Forecast - 30 Days FREE Trial $132M 11.7x 2.4x
CCLDO Unlock Forecast - 30 Days FREE Trial $906M 80.4x 16.2x
CCSI Unlock Forecast - 30 Days FREE Trial $510M 6.3x -8.3x
CDNS Unlock Forecast - 30 Days FREE Trial $89016M 88.0x 17.8x
CERT Unlock Forecast - 30 Days FREE Trial $1937M 242.7x 1.8x
CFLT Unlock Forecast - 30 Days FREE Trial $7714M -15.7x 7.3x
CGNT Unlock Forecast - 30 Days FREE Trial $639M x 3.2x
CHKP Unlock Forecast - 30 Days FREE Trial $21032M x 7.5x
CLBT Unlock Forecast - 30 Days FREE Trial $4755M x 11.6x
CLPS Unlock Forecast - 30 Days FREE Trial $13M x 0.8x
COUR Unlock Forecast - 30 Days FREE Trial $1685M -14.2x 2.7x
CRM Unlock Forecast - 30 Days FREE Trial $231618M 34.8x 3.8x
CRNC Unlock Forecast - 30 Days FREE Trial $458M -0.5x 2.9x
CRWD Unlock Forecast - 30 Days FREE Trial $121835M 4606.3x 32.4x
CRWV Unlock Forecast - 30 Days FREE Trial $49415M x 18.6x
CVLT Unlock Forecast - 30 Days FREE Trial $7758M 95.7x 21.3x
CWAN Unlock Forecast - 30 Days FREE Trial $4548M 11.2x 2.3x
CXM Unlock Forecast - 30 Days FREE Trial $1986M 16.5x 3.7x
CYBR Unlock Forecast - 30 Days FREE Trial $24283M x 10.3x
DAY Unlock Forecast - 30 Days FREE Trial $10898M 222.4x 4.0x
DDD Unlock Forecast - 30 Days FREE Trial $534M -3.9x 2.2x
DDOG Unlock Forecast - 30 Days FREE Trial $58124M 466.6x 18.2x
DH Unlock Forecast - 30 Days FREE Trial $427M -1.3x 1.4x
DOCU Unlock Forecast - 30 Days FREE Trial $13747M 48.9x 6.9x
DRTTF Unlock Forecast - 30 Days FREE Trial $119M 30.8x 3.5x
DSGX Unlock Forecast - 30 Days FREE Trial $8383M x 5.6x
DT Unlock Forecast - 30 Days FREE Trial $14537M 29.5x 5.4x
DTSS Unlock Forecast - 30 Days FREE Trial $15M -6.8x 5.3x
DUOL Unlock Forecast - 30 Days FREE Trial $16221M 138.4x 16.6x
EA Unlock Forecast - 30 Days FREE Trial $50250M 48.2x 8.3x
EGAN Unlock Forecast - 30 Days FREE Trial $366M 11.4x 4.5x
EVCM Unlock Forecast - 30 Days FREE Trial $2020M -59.0x 2.7x
EXFY Unlock Forecast - 30 Days FREE Trial $151M -12.3x 1.1x
FALC Unlock Forecast - 30 Days FREE Trial $1M x x
FATN Unlock Forecast - 30 Days FREE Trial $75M x 3.7x
FCUL Unlock Forecast - 30 Days FREE Trial $8M x 174.7x
FNGR Unlock Forecast - 30 Days FREE Trial $107M -16.8x 6.6x
FROG Unlock Forecast - 30 Days FREE Trial $5477M -60.2x 6.6x
FRSH Unlock Forecast - 30 Days FREE Trial $3309M -49.0x 3.4x
FRSX Unlock Forecast - 30 Days FREE Trial $1527M x 257.4x
FRZT Unlock Forecast - 30 Days FREE Trial $2M x x
FSLY Unlock Forecast - 30 Days FREE Trial $1190M -8.6x 1.3x
GEG Unlock Forecast - 30 Days FREE Trial $108M 8.4x 1.5x
GEGGL Unlock Forecast - 30 Days FREE Trial $1087M 84.3x 15.5x
GHST Unlock Forecast - 30 Days FREE Trial $6M x x
GLBE Unlock Forecast - 30 Days FREE Trial $5776M x 6.5x
GMGI Unlock Forecast - 30 Days FREE Trial $138M -247.8x 1.1x
GTIC Unlock Forecast - 30 Days FREE Trial $0M 0.1x x
GTLB Unlock Forecast - 30 Days FREE Trial $7396M 654.1x 8.5x
GWRE Unlock Forecast - 30 Days FREE Trial $20303M 290.9x 13.9x
GXAI Unlock Forecast - 30 Days FREE Trial $13M -1.3x 0.9x
HPAI Unlock Forecast - 30 Days FREE Trial $130M x 8.0x
HUBS Unlock Forecast - 30 Days FREE Trial $24062M -5033.1x 11.7x
IDAI Unlock Forecast - 30 Days FREE Trial $9M -0.7x 3.9x
IFBD Unlock Forecast - 30 Days FREE Trial $9M x 0.1x
INFA Unlock Forecast - 30 Days FREE Trial $7537M 3931.5x 3.2x
INLX Unlock Forecast - 30 Days FREE Trial $53M 1318.3x 4.5x
INSE Unlock Forecast - 30 Days FREE Trial $240M 4.0x -116.0x
INTA Unlock Forecast - 30 Days FREE Trial $3085M -173.7x 5.9x
INTU Unlock Forecast - 30 Days FREE Trial $183432M 47.4x 9.3x
JAMF Unlock Forecast - 30 Days FREE Trial $1319M -22.8x 1.7x
KC Unlock Forecast - 30 Days FREE Trial $46548M x 4.9x
KLTR Unlock Forecast - 30 Days FREE Trial $229M 17.7x 13.5x
KVYO Unlock Forecast - 30 Days FREE Trial $6835M -19.1x 6.2x
LAW Unlock Forecast - 30 Days FREE Trial $375M -12.7x 2.7x
LFLY Unlock Forecast - 30 Days FREE Trial $112M -0.3x -4.0x
LPSN Unlock Forecast - 30 Days FREE Trial $590M -0.5x -1.2x
MANH Unlock Forecast - 30 Days FREE Trial $12126M 54.8x 43.5x
MBLY Unlock Forecast - 30 Days FREE Trial $12521M -9.4x 1.0x
MGIC Unlock Forecast - 30 Days FREE Trial $1042M x 5.0x
MLNK Unlock Forecast - 30 Days FREE Trial $1484M -46.1x 3.8x
MNDY Unlock Forecast - 30 Days FREE Trial $9674M x 8.1x
MQ Unlock Forecast - 30 Days FREE Trial $2312M 51.0x 2.7x
MSFT Unlock Forecast - 30 Days FREE Trial $3817879M 37.5x 11.1x
MTBLY Unlock Forecast - 30 Days FREE Trial $1608M x 33.3x
MTC Unlock Forecast - 30 Days FREE Trial $21M x x
MYPS Unlock Forecast - 30 Days FREE Trial $118M -24.1x 0.5x
MYPSW Unlock Forecast - 30 Days FREE Trial $2M -0.4x 0.0x
MYSZ Unlock Forecast - 30 Days FREE Trial $4M -0.3x 0.5x
NABL Unlock Forecast - 30 Days FREE Trial $1441M 503.2x 1.8x
NCNO Unlock Forecast - 30 Days FREE Trial $2839M -119.0x 2.7x
NCSYF Unlock Forecast - 30 Days FREE Trial $8975M x 2.5x
NICE Unlock Forecast - 30 Days FREE Trial $8315M x 2.3x
NOW Unlock Forecast - 30 Days FREE Trial $189104M 113.9x 17.3x
ONTF Unlock Forecast - 30 Days FREE Trial $227M -6.7x 1.5x
OS Unlock Forecast - 30 Days FREE Trial $4078M x 10.6x
PATH Unlock Forecast - 30 Days FREE Trial $8936M 443.1x 5.4x
PAYC Unlock Forecast - 30 Days FREE Trial $11270M 27.1x 6.3x
PCOR Unlock Forecast - 30 Days FREE Trial $10854M -134.0x 8.9x
PCTY Unlock Forecast - 30 Days FREE Trial $8375M 36.9x 6.8x
PD Unlock Forecast - 30 Days FREE Trial $1484M -23.5x 8.2x
PLTR Unlock Forecast - 30 Days FREE Trial $426316M 558.5x 71.9x
PRCH Unlock Forecast - 30 Days FREE Trial $1791M 32.1x -22.8x
PRGS Unlock Forecast - 30 Days FREE Trial $1965M 40.5x 4.1x
PTC Unlock Forecast - 30 Days FREE Trial $24205M 47.2x 6.9x
QLYS Unlock Forecast - 30 Days FREE Trial $4612M 24.9x 9.1x
QTWO Unlock Forecast - 30 Days FREE Trial $3881M 794.6x 6.6x
RBLX Unlock Forecast - 30 Days FREE Trial $92385M -35.7x 261.6x
RBRK Unlock Forecast - 30 Days FREE Trial $15109M x 0.0x
RDVT Unlock Forecast - 30 Days FREE Trial $743M 85.4x 7.7x
RPD Unlock Forecast - 30 Days FREE Trial $1205M 47.2x 13.3x
RTCJF Unlock Forecast - 30 Days FREE Trial $40M x 1.5x
S Unlock Forecast - 30 Days FREE Trial $5611M -25.6x 3.7x
SAIL Unlock Forecast - 30 Days FREE Trial $12418M -73.2x 1.8x
SBET Unlock Forecast - 30 Days FREE Trial $1015M x 2.2x
SEMR Unlock Forecast - 30 Days FREE Trial $1080M 169.4x 3.9x
SHOP Unlock Forecast - 30 Days FREE Trial $200038M x 16.5x
SMSI Unlock Forecast - 30 Days FREE Trial $15M -0.2x 0.7x
SNAL Unlock Forecast - 30 Days FREE Trial $0M -7.0x 0.0x
SNPS Unlock Forecast - 30 Days FREE Trial $82300M 41.2x 3.0x
SPNS Unlock Forecast - 30 Days FREE Trial $2408M x 5.0x
SPSC Unlock Forecast - 30 Days FREE Trial $4144M 50.0x 4.4x
SSNC Unlock Forecast - 30 Days FREE Trial $20223M 25.1x 2.9x
SSTI Unlock Forecast - 30 Days FREE Trial $145M -38.0x 1.9x
SVCO Unlock Forecast - 30 Days FREE Trial $172M x 2.2x
TAOP Unlock Forecast - 30 Days FREE Trial $19M x 1.2x
TDC Unlock Forecast - 30 Days FREE Trial $2043M 18.6x 11.6x
TEAM Unlock Forecast - 30 Days FREE Trial $40936M -233.9x 30.4x
TENB Unlock Forecast - 30 Days FREE Trial $3522M -81.5x 10.0x
TFLM Unlock Forecast - 30 Days FREE Trial $1M x x
TTAN Unlock Forecast - 30 Days FREE Trial $8832M x 5.9x
TTWO Unlock Forecast - 30 Days FREE Trial $47524M -9.7x 13.7x
TWLO Unlock Forecast - 30 Days FREE Trial $17375M 858.3x 2.2x
TYL Unlock Forecast - 30 Days FREE Trial $24376M 79.5x 6.7x
U Unlock Forecast - 30 Days FREE Trial $15380M -13.5x 4.8x
VBIX Unlock Forecast - 30 Days FREE Trial $37M x 8.2x
VEEV Unlock Forecast - 30 Days FREE Trial $47139M 58.2x 7.1x
VPRB Unlock Forecast - 30 Days FREE Trial $M x x
VRNS Unlock Forecast - 30 Days FREE Trial $6852M -27.4x 20.1x
VWAV Unlock Forecast - 30 Days FREE Trial $23M x x
WBSR Unlock Forecast - 30 Days FREE Trial $M x x
WEAV Unlock Forecast - 30 Days FREE Trial $506M -36.7x 6.4x
WFCF Unlock Forecast - 30 Days FREE Trial $63M 30.7x 6.3x
WHEN Unlock Forecast - 30 Days FREE Trial $309M x 227.6x
WIMI Unlock Forecast - 30 Days FREE Trial $152M x 0.1x
XPER Unlock Forecast - 30 Days FREE Trial $350M -4.3x 0.8x
XYZ Unlock Forecast - 30 Days FREE Trial $47773M 16.2x 2.2x
ZDGE Unlock Forecast - 30 Days FREE Trial $43M -4.8x 1.5x
ZETA Unlock Forecast - 30 Days FREE Trial $4129M -26.5x 6.1x
ZSPC Unlock Forecast - 30 Days FREE Trial $29M x -3.2x

Frequently Asked Questions - SYNOPSYS INC Stock Forecast

How accurate are SYNOPSYS INC stock predictions?

Our AI model demonstrates 72% historical accuracy for SNPS predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence SYNOPSYS INC stock price forecasts?

Our analysis considers SYNOPSYS INC's financial metrics, Technology sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is SYNOPSYS INC a good investment in 2025?

Based on our AI analysis, SYNOPSYS INC shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are SYNOPSYS INC forecasts updated?

SYNOPSYS INC stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced SYNOPSYS INC Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for SYNOPSYS INC stock.

My Portfolio

Investment Dashboard

Loading your portfolio...